USD 0.0
(-90.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | -14.86 Million | -11.7 Million | -2.19 Million | -1.59 Million |
Net Income | - | - | -37.95 Million | -12.15 Million | -1.56 Million | -1.12 Million |
Depreciation & Amortization | - | - | 634.51 Thousand | 278.12 Thousand | 6255.00 | 1825.00 |
Deferred income taxes | - | - | 18.78 Million | 78.92 Thousand | - | - |
Stock-based compensation | - | - | 3524.34 | 125.61 | - | - |
Change in working capital | - | - | 109.94 Thousand | -49.18 Thousand | -766.47 Thousand | -627.83 Thousand |
Other non-cash items | - | - | 40.13 Thousand | 8554.00 | 130.45 Thousand | 157.81 Thousand |
Investing Cash Flow | - | - | -2.02 Million | -4.45 Million | -12.66 Thousand | -12.17 Thousand |
Investments in PPE | - | - | -254.27 Thousand | -104.57 Thousand | -12.66 Thousand | -12.17 Thousand |
Acquisitions | - | - | -1.77 Million | -4.34 Million | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | -110.87 Thousand | 41.14 Million | 3.37 Million | 1.63 Million |
Debt repayment | - | - | -85.64 Thousand | -51.12 Thousand | -47.45 Thousand | -1.69 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 41.33 Million | 3.04 Million | - |
Other Financing Activities | - | - | -25.23 Thousand | -133.1 Thousand | 331.89 Thousand | 1.63 Million |
Accounts receivables | - | - | 138.4 Thousand | -179.63 Thousand | -271.58 Thousand | -95.06 Thousand |
Accounts payables | - | - | 552.79 Thousand | 1.46 Million | 48.35 Thousand | 116.98 Thousand |
Inventory | - | - | -804.83 Thousand | -580.97 Thousand | -545.63 Thousand | 50.42 Thousand |
Other working capital | - | - | 223.57 Thousand | -756.01 Thousand | 50.73 Thousand | -583.19 Thousand |
Cash at beginning of period | - | 9.26 Million | 26.25 Million | 1.27 Million | 107.94 Thousand | 73.95 Thousand |
Cash at end of period | - | 9.26 Million | 9.26 Million | 26.25 Million | 1.27 Million | 107.94 Thousand |
Capital Expenditure | - | - | -254.27 Thousand | -104.57 Thousand | -12.66 Thousand | -12.17 Thousand |
Effect of forex changes on cash | - | - | 1.00 | - | - | - |
Net cash flow / Change in cash | - | - | -16.99 Million | 24.98 Million | 1.16 Million | 33.99 Thousand |
Free Cash Flow | - | - | -15.11 Million | -11.81 Million | -2.2 Million | -1.6 Million |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
002329
IPHYF
CVLT
MYOR
VQS
GYRE